Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is ovarian germ cell tumors?
Ovarian germ cell tumors are cancers that begin in the egg-producing (germ) cells of the ovary. They are very different from the common epithelial ovarian cancer that affects older women: germ cell tumors occur mainly in girls and young women, often in the teens and twenties, and they tend to grow quickly but respond extremely well to treatment, making them among the most curable of all cancers. Because a fast-growing mass can stretch the ovary, the first symptoms are often belly pain or swelling, a feeling of fullness or pressure, or a mass the patient or a doctor can feel. Many of these tumors release substances into the blood — tumor markers such as AFP and beta-hCG — that help diagnose them, track how well treatment is working, and watch for any return. There are several subtypes. The most common malignant one is the dysgerminoma; others include the yolk sac tumor, immature teratoma, embryonal carcinoma, choriocarcinoma, and mixed tumors that contain more than one of these. (A separate, very common type — the mature cystic teratoma, or dermoid cyst — is benign and not cancer.) The guiding principles of care are shaped by who these patients are: because they are usually young, treatment is designed to cure the cancer while preserving fertility whenever possible. That typically means removing just the affected ovary rather than both, and giving chemotherapy — which is remarkably effective for these tumors — when more than surgery is needed. Radiation, once used more often (especially the radiation-sensitive dysgerminoma), now plays a limited, selective role because chemotherapy is so effective and spares fertility.
The main types
Doctors group ovarian germ cell tumors by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Dysgerminoma | The most common malignant ovarian germ cell tumor and notably sensitive to both chemotherapy and radiation; highly curable, often with surgery alone for early tumors. |
| Yolk sac tumor (endodermal sinus tumor) | A faster-growing type that usually produces the marker AFP; treated with surgery plus chemotherapy, with excellent cure rates. |
| Immature teratoma | Contains immature tissues and is graded by how immature they are; early low-grade tumors may need surgery alone, while higher-grade or advanced ones add chemotherapy. |
| Other and mixed germ cell tumors | Embryonal carcinoma, choriocarcinoma, and tumors containing a mix of types; treated with surgery and chemotherapy guided by the components present and the tumor markers. |
Staging, in plain terms
Ovarian germ cell tumors are staged with the FIGO system, the same framework used for other ovarian and gynecologic cancers, running from stage I to stage IV. Stage I means the tumor is confined to the ovary or ovaries; stage II means it has spread within the pelvis; stage III means it has spread to the lining of the abdomen or to lymph nodes; and stage IV means it has spread to distant organs. Staging is usually done at the time of the first surgery, when the surgeon removes the tumor and inspects and samples areas where these cancers tend to spread. But for germ cell tumors, stage works together with two other crucial pieces of information. The first is the subtype and, for immature teratomas, the grade, since these influence how the tumor behaves and whether chemotherapy is needed. The second is the blood tumor markers — AFP and beta-hCG — which many of these tumors release; they help confirm the diagnosis, are followed during treatment to confirm the cancer is responding, and serve as an early warning if the cancer comes back. A defining feature of these cancers is that even when they are found at an advanced stage, cure rates remain very high because they respond so well to chemotherapy. As a result, staging guides how much treatment is needed — many early tumors are cured by fertility-sparing surgery alone, while higher stages add highly effective chemotherapy — rather than signaling a poor outlook the way an advanced stage might in other cancers.
| FIGO staging (I–IV), used alongside subtype, grade, and blood tumor markers | What it generally means |
|---|---|
| Stage I | Confined to one or both ovaries; often cured by fertility-sparing surgery alone, with chemotherapy added only for certain subtypes or higher-grade tumors, and very high cure rates. |
| Stage II | Spread to other structures within the pelvis; treated with surgery plus chemotherapy, still with excellent outcomes. |
| Stage III | Spread to the lining of the abdomen or to lymph nodes; treated with surgery and chemotherapy, and remarkably, most patients are still cured. |
| Stage IV | Spread to distant organs such as the liver or lungs; treated with chemotherapy and surgery, and even here cure is often achievable because these tumors are so chemotherapy-sensitive. |
The standard of care
Ovarian Germ Cell Tumors is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Fertility-sparing surgery
Removing the affected ovary and tube while preserving the uterus and the other ovary, so future pregnancy remains possible — the standard approach for most young patients, combined with surgical staging.
Chemotherapy (BEP)
A highly effective three-drug combination (bleomycin, etoposide, and cisplatin) that cures the great majority of germ cell tumors needing more than surgery, even when advanced.
Active surveillance for selected early tumors
For certain stage I tumors, close monitoring with exams, tumor-marker blood tests, and imaging after surgery can avoid chemotherapy in patients who may never need it.
Tumor-marker monitoring
Tracking AFP and beta-hCG in the blood guides treatment, confirms the cancer is responding, and provides early warning of any recurrence.
Radiation therapy in selected cases
Reserved for specific situations — historically for the radiation-sensitive dysgerminoma and now mainly for treating particular sites of disease — because chemotherapy is so effective and preserves fertility.
How radiation treatment works
Radiation therapy uses focused beams of energy to damage the DNA inside cancer cells so they can no longer grow and divide. Ovarian germ cell tumors — especially the dysgerminoma subtype — are quite sensitive to radiation, and decades ago radiation was a more common part of treatment. Today its role is deliberately limited, and understanding why tells the story of how care for these cancers has improved. These tumors usually occur in girls and young women, for whom preserving fertility and avoiding long-term effects on healthy tissue is a priority, and chemotherapy turned out to be so effective at curing them — even when advanced — that it largely replaced radiation as the treatment added to surgery. Chemotherapy also has the advantage of treating the whole body and sparing the ovaries and uterus, whereas radiation aimed at the abdomen or pelvis can affect fertility. As a result, modern radiation is reserved for selective situations: treating a specific area of residual or recurrent disease (particularly with the radiation-sensitive dysgerminoma) when chemotherapy is not the best option, controlling an isolated tumor deposit with precise high-dose techniques, or relieving symptoms such as pain or pressure with a short palliative course. When radiation is used in a young patient, it is planned carefully to shield the remaining ovary and the uterus as much as possible. The broader message is an encouraging one: because surgery and chemotherapy cure the overwhelming majority of these patients, radiation is no longer a routine part of treatment, but it remains a useful, precise tool for the specific circumstances where it offers the clearest benefit.
The main ways radiation is delivered for ovarian germ cell tumors:
Selective external-beam radiation
Focused external-beam radiation can treat specific areas of disease — such as residual or recurrent tumor in lymph nodes — particularly for dysgerminoma, which is highly radiation-sensitive, when chemotherapy is not the preferred choice.
Palliative radiation
A short, targeted course of radiation can relieve symptoms from a tumor that is pressing on a structure or causing pain, improving comfort when needed.
Stereotactic radiation for isolated spots
Precise, high-dose radiation can control a small number of isolated tumor deposits, for example in selected recurrences, while sparing surrounding tissue.
Fertility-protective planning
When radiation is used in a young patient, treatment is planned to shield the remaining ovary and uterus as much as possible to protect future fertility.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Fertility-sparing surgery is safe for most germ cell tumors: Studies confirm that removing only the affected ovary, rather than both, does not reduce cure rates for ovarian germ cell tumors and preserves the ability to have children, establishing it as the standard approach for young patients.[1]
Fertility-sparing surgery outcome studies
Surveillance avoids chemotherapy in selected stage I tumors: Careful monitoring after surgery for certain early-stage germ cell tumors allows many patients to avoid chemotherapy entirely, with cure achieved by surgery alone and treatment reserved for the few who relapse.[2]
Stage I germ cell tumor surveillance trials
Chemotherapy delivers high cure rates even in advanced disease: Cisplatin-based combination chemotherapy (BEP) cures the great majority of patients with ovarian germ cell tumors, including those with advanced disease, which is why it — rather than radiation — is the treatment added to surgery.[3]
Germ cell tumor chemotherapy series
Common questions
Will I be able to have children after treatment? Very often, yes. Because these cancers mostly affect young women and are so curable, treatment is designed to preserve fertility. The standard surgery removes only the affected ovary and tube, leaving the uterus and the other ovary in place, and the highly effective chemotherapy used when needed generally allows fertility to be preserved. Discuss fertility planning with your team before treatment begins.
Why isn't radiation used much for this cancer anymore? Even though some of these tumors — especially dysgerminoma — are sensitive to radiation, chemotherapy turned out to cure them just as well or better while sparing the ovaries and uterus. Since radiation aimed at the pelvis can affect fertility, it has been largely replaced by chemotherapy and is now reserved for selective situations, such as treating a specific area of disease or relieving symptoms.
What are tumor markers, and why are my blood levels being checked? Many ovarian germ cell tumors release substances called AFP and beta-hCG into the blood. Measuring them helps confirm the diagnosis, shows whether treatment is working as the levels fall, and provides an early warning if the cancer comes back. That is why your team checks these blood markers during and after treatment.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.